Role of GLP-1 receptor agonists in the prevention and treatment of obesity-related cancer.

Muscogiuri G, Del Vecchio G, Colangeli L, Guglielmi V, Sbraccia P, Colao A

Open source

DOI
10.1007/s11739-026-04458-z
Published
2026 Jul 7
Container
Internal and emergency medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11739-026-04458-z,
  title = {Role of GLP-1 receptor agonists in the prevention and treatment of obesity-related cancer.},
  author = {Muscogiuri G and Del Vecchio G and Colangeli L and Guglielmi V and Sbraccia P and Colao A},
  year = {2026},
  journal = {Internal and emergency medicine},
  doi = {10.1007/s11739-026-04458-z},
  url = {https://doi.org/10.1007/s11739-026-04458-z}
}

RIS

TY  - JOUR
TI  - Role of GLP-1 receptor agonists in the prevention and treatment of obesity-related cancer.
AU  - Muscogiuri G
AU  - Del Vecchio G
AU  - Colangeli L
AU  - Guglielmi V
AU  - Sbraccia P
AU  - Colao A
PY  - 2026
JO  - Internal and emergency medicine
DO  - 10.1007/s11739-026-04458-z
UR  - https://doi.org/10.1007/s11739-026-04458-z
ER  - 

APA

G, M., G, D. V., L, C., V, G., P, S., & A, C. (2026). Role of GLP-1 receptor agonists in the prevention and treatment of obesity-related cancer.. Internal and emergency medicine. https://doi.org/10.1007/s11739-026-04458-z

Source records